AdvanSource Biomaterials Corp·4

Dec 6, 5:56 PM ET

BARRETTI MICHAEL L 4

4 · AdvanSource Biomaterials Corp · Filed Dec 6, 2019

Insider Transaction Report

Form 4
Period: 2019-12-05
Transactions
  • Exercise of In-Money

    Common Stock

    2019-12-05+525,000525,115 total
Footnotes (1)
  • [F1]Shares acquired from the exercise of options pursuant to the 2017 Non-Qualified Equity Incentive Plan (the "2017 Plan") which provided for the exercise of options into 750,000 shares of the Company's common stock at an exercise price of $0.06 per share which were exercised on a cashless basis, as provided for in the 2017 Plan, resulting in the issuance of 525,000 shares, net.

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT